Rallis India Ltd

- There is no mention of any current or planned new fundraising through debt or equity in the provided transcript. - The company reports a healthy cash and liquid balance of INR454 crores as of September 30, 2025. - Planned capital expenditure for the year is around INR50 crores, indicating controlled capex outlay. - The focus appears to be on improving capital efficiency, including working capital optimization and inventory moderation. - No specific discussions or announcements about raising funds via debt or equity were noted during the call.

- Rallis India Limited reported a planned capital expenditure (capex) of around INR 50 crores. - The company is focused on improving capital efficiency for both fixed capital and working capital. - Efforts include portfolio optimization, territory rationalization, and cost efficiencies to support growth. - Strategic investments focus on expanding product portfolio, launching new products in crop protection and seeds. - R&D focus has been sharpened, with annual budget around INR 60-70 crores, aiming for patent registrations and new product launches. - The company is also investing in digitalization and focused village-based marketing to enhance market reach. - No specific large-scale future strategic investments announced, but continuous focus on research, product development, and expanding export markets.

- Industry growth expected to be low to mid-single digit; too early for concrete comments (Gyanendra Shukla). - Domestic business saw ~10% decline in Q2 volume; some key regions like Maharashtra and Punjab affected. - Export business grew over 30% in H1, driven mainly by volume (85-90%) and some pricing efficiency. - New geographies for exports added (France, Malaysia, Spain), though bulk growth from existing markets. - Significant volume expansion planned in cotton seeds (products like Diggaz) with only 50-60% potential harnessed so far. - Focus on key crops: cotton, maize, millet, mustard, and rice for seed business aiming for scale. - R&D focused on modern breeding and biotechnology tools; new product launches including wheat and rice herbicides anticipated next year. - Expect recovery in Soil and Plant Health business post rain-related impacts; aimed 20% growth but flat so far. - Efforts on portfolio optimization, cost efficiencies, new products, and digitalization to drive consistent profitable growth.

- Industry growth is expected to remain at low to mid-single digits, indicating moderate top-line growth prospects. - Domestic business saw a ~10% decline in Q2, impacted by rainfall and volume softness, with pricing remaining subdued. - Export business grew notably (~30-50% H1 growth), driven primarily by volume and new customer additions, signaling strong overseas growth potential. - Focus on higher-margin Soil and Plant Health and Seed segments, with targeted crop focus aiding scale and profitability. - R&D focus on modern breeding and 9(3) registrations is expected to launch new herbicides next year, supporting future product pipeline and margins. - Cost efficiencies, portfolio optimization, digital reach, and channel strategy expected to drive margin expansion and profitability. - FY26 R&D spend at INR60-70 crores with emphasis on focused investments, indicating sustained innovation-led growth. - EBITDA margins aimed around 23-25% for seed business, indicative of operating profitability improvement. - Overall, the company targets consistent, competitive, and profitable growth despite near-term weather-related challenges.

- On page 12, Gyanendra Shukla mentions that cotton seed production is still in the field and will start coming from quarter 3 onwards to the warehouse. - The seeds have to undergo multiple quality tests before sale. - There is a planned significant volume expansion for cotton seeds, indicating a growing order book or pending orders to be fulfilled in the upcoming quarters. - No specific numeric details of the current or expected order book/pending orders were mentioned in the transcript.